Responses
Regular and Young Investigator Award Abstracts
Biomarkers, Immune Monitoring, and Novel Technologies
5 CD274 (PD-L1) gene expression and the 27-gene immuno-oncology (IO) assay are associated with efficacy to immune checkpoint inhibitor treated patients with non-small cell lung cancer (NSCLC)
Compose a Response to This Article
Other responses
No responses have been published for this article.